SAMSRITA LABS last traded at ₹11.45 (2026-10-13). Over the past month the stock moved -3.9%, three months the stock moved -24.5%, year the stock moved -41.3%. Its closing range over 52 weeks is ₹10.60 – ₹23.99, with the latest close 52.3% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1996, Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)
Products & R&D[1] 1. Stem Cell R&D: Focuses on regenerative medicine, stem cell therapies, bioengineered organs, nanobiotechnology, and advanced research for chronic and end-stage diseases. Published 250+ international papers and holds 2 patents. 2. New Drug Discovery: Develops IP-protected drug candidates for orphan and specialty diseases, with 11 international patents and a focus on the USFDA 505(b)(2) pathway. 3. RNA Interference: Develops miRNA-based biomarkers and molecular diagnostic kits, with a focus on patented diagnostic technologies. 4. Molecular Biomarkers 5. Medical Devices: Develops advanced medical devices, including extracorporeal support systems, implantable devices, CTC removal technologies, and nanotechnology-based treatment platforms.
In the latest quarter (Jun 2026), SAMSRITA LABS reported sales of ₹0.00 crore and net profit of ₹-0.19 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.31 | – | -0.19 | -0.08 |
| Mar 2026 | 0.02 | -0.15 | -750.00 | -0.48 | -0.21 |
| Dec 2025 | 0.00 | -3.36 | – | -2.94 | -1.29 |
| Sep 2025 | 0.00 | -4.93 | – | -4.55 | -2.00 |
| Dec 2024 | 0.00 | 0.00 | – | 0.00 | 0.00 |
| Sep 2021 | 0.00 | -0.06 | – | -0.02 | -0.01 |
| Jun 2021 | 0.00 | -0.08 | – | -0.04 | -0.03 |
| Mar 2021 | 0.00 | -0.07 | – | -0.01 | -0.01 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2024 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -100.0% | -100.0% | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | – | – | – | – | – | – | -750.0% | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), SAMSRITA LABS reported sales of ₹0.02 crore and net profit of ₹-8.16 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.02 | -8.71 | -43,550.00 | -8.16 | -3.59 |
| Mar 2025 | 0.00 | -0.26 | – | -0.26 | -0.18 |
| Mar 2024 | 0.00 | -0.25 | – | -0.25 | -0.17 |
| Mar 2023 | 0.02 | -0.99 | -4,950.00 | -0.71 | -0.48 |
| Mar 2022 | 0.02 | -0.41 | -2,050.00 | 1.50 | 1.01 |
| Mar 2021 | 0.01 | -0.91 | -9,100.00 | -0.77 | -0.52 |
| Mar 2020 | 1.43 | -2.03 | -141.96 | -1.89 | -1.28 |
| Mar 2019 | 1.90 | -2.23 | -117.37 | -2.14 | -1.55 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +206.5% | -24.7% | -99.3% | +100.0% | +0.0% | -100.0% | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | -147.3% | – | – | – |
| EPS growth | – | – | – | – | -147.5% | – | – | – |
| OPM % | -117.4% | -142.0% | -9100.0% | -2050.0% | -4950.0% | – | – | -43550.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for SAMSRITA LABS.
Get Free AI Stock Analysis FREE →Samsrita Labs approves ₹26 crore RPTs with S Labs Hygiene Care - scanx.trade
SAMSRITA LABS shares were last quoted at ₹11.45 (-3.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
SAMSRITA LABS has a price-to-earnings (P/E) ratio of -3.24 and a price-to-book (P/B) ratio of 2.47. The industry P/E is 101.02.
The 52-week high of SAMSRITA LABS is ₹25.27 and the 52-week low is ₹10.15.
The market capitalisation of SAMSRITA LABS is about ₹28.23 crore.
In the latest quarter (Jun 2026), SAMSRITA LABS reported sales of ₹0.00 crore and net profit of ₹-0.19 crore, compared with the same quarter last year.
Promoters hold about 25.44% of SAMSRITA LABS.
SAMSRITA LABS belongs to the Trading sector.